Adhera Therapeutics, Inc. announced that its Board of Directors has appointed Nancy R. Phelan to serve as Chief Executive Officer of the company. Ms. Phelan has served as a member of the Board of Directors since October 2018. In connection with the appointment of Ms. Phelan as Chief Executive Officer of Adhera, Robert C. Moscato, Jr. resigned from such position, as well as from his position as a member of the Board of Directors, effective April 4, 2019.